IBDEI16M ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,20872,1,3,0)
 ;;=3^V72.40
 ;;^UTILITY(U,$J,358.3,20872,1,4,0)
 ;;=4^Pregnancy Exam/Test
 ;;^UTILITY(U,$J,358.3,20872,2)
 ;;=^331589
 ;;^UTILITY(U,$J,358.3,20873,0)
 ;;=V72.31^^112^1293^27
 ;;^UTILITY(U,$J,358.3,20873,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20873,1,3,0)
 ;;=3^V72.31
 ;;^UTILITY(U,$J,358.3,20873,1,4,0)
 ;;=4^Gyn Examination, Routine
 ;;^UTILITY(U,$J,358.3,20873,2)
 ;;=^331587
 ;;^UTILITY(U,$J,358.3,20874,0)
 ;;=V67.01^^112^1293^32
 ;;^UTILITY(U,$J,358.3,20874,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20874,1,3,0)
 ;;=3^V67.01
 ;;^UTILITY(U,$J,358.3,20874,1,4,0)
 ;;=4^Pap Smear Following Surgery
 ;;^UTILITY(U,$J,358.3,20874,2)
 ;;=^322078
 ;;^UTILITY(U,$J,358.3,20875,0)
 ;;=627.4^^112^1293^10
 ;;^UTILITY(U,$J,358.3,20875,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20875,1,3,0)
 ;;=3^627.4
 ;;^UTILITY(U,$J,358.3,20875,1,4,0)
 ;;=4^Artificial Menopause-Symptomatic
 ;;^UTILITY(U,$J,358.3,20875,2)
 ;;=^328736
 ;;^UTILITY(U,$J,358.3,20876,0)
 ;;=793.80^^112^1293^1
 ;;^UTILITY(U,$J,358.3,20876,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20876,1,3,0)
 ;;=3^793.80
 ;;^UTILITY(U,$J,358.3,20876,1,4,0)
 ;;=4^Abnormal Mammogram
 ;;^UTILITY(U,$J,358.3,20876,2)
 ;;=^323613
 ;;^UTILITY(U,$J,358.3,20877,0)
 ;;=V76.47^^112^1293^39
 ;;^UTILITY(U,$J,358.3,20877,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20877,1,3,0)
 ;;=3^V76.47
 ;;^UTILITY(U,$J,358.3,20877,1,4,0)
 ;;=4^Special Screening for Vaginal Malig
 ;;^UTILITY(U,$J,358.3,20877,2)
 ;;=^322085
 ;;^UTILITY(U,$J,358.3,20878,0)
 ;;=V45.77^^112^1293^7
 ;;^UTILITY(U,$J,358.3,20878,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20878,1,3,0)
 ;;=3^V45.77
 ;;^UTILITY(U,$J,358.3,20878,1,4,0)
 ;;=4^Acquired Absence of Uterus
 ;;^UTILITY(U,$J,358.3,20878,2)
 ;;=^322067
 ;;^UTILITY(U,$J,358.3,20879,0)
 ;;=233.1^^112^1293^12
 ;;^UTILITY(U,$J,358.3,20879,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20879,1,3,0)
 ;;=3^233.1
 ;;^UTILITY(U,$J,358.3,20879,1,4,0)
 ;;=4^CA in Situ (Sev. Dysplasia),Cervix
 ;;^UTILITY(U,$J,358.3,20879,2)
 ;;=^267736
 ;;^UTILITY(U,$J,358.3,20880,0)
 ;;=795.01^^112^1293^4
 ;;^UTILITY(U,$J,358.3,20880,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20880,1,3,0)
 ;;=3^795.01
 ;;^UTILITY(U,$J,358.3,20880,1,4,0)
 ;;=4^Abnormal Pap-ASC-US
 ;;^UTILITY(U,$J,358.3,20880,2)
 ;;=^331972
 ;;^UTILITY(U,$J,358.3,20881,0)
 ;;=795.02^^112^1293^3
 ;;^UTILITY(U,$J,358.3,20881,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20881,1,3,0)
 ;;=3^795.02
 ;;^UTILITY(U,$J,358.3,20881,1,4,0)
 ;;=4^Abnormal Pap-ASC-H
 ;;^UTILITY(U,$J,358.3,20881,2)
 ;;=^331973
 ;;^UTILITY(U,$J,358.3,20882,0)
 ;;=795.03^^112^1293^6
 ;;^UTILITY(U,$J,358.3,20882,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20882,1,3,0)
 ;;=3^795.03
 ;;^UTILITY(U,$J,358.3,20882,1,4,0)
 ;;=4^Abnormal Pap-LGSIL
 ;;^UTILITY(U,$J,358.3,20882,2)
 ;;=^331571
 ;;^UTILITY(U,$J,358.3,20883,0)
 ;;=795.04^^112^1293^5
 ;;^UTILITY(U,$J,358.3,20883,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20883,1,3,0)
 ;;=3^795.04
 ;;^UTILITY(U,$J,358.3,20883,1,4,0)
 ;;=4^Abnormal Pap-HGSIL
 ;;^UTILITY(U,$J,358.3,20883,2)
 ;;=^331572
 ;;^UTILITY(U,$J,358.3,20884,0)
 ;;=795.05^^112^1293^13
 ;;^UTILITY(U,$J,358.3,20884,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20884,1,3,0)
 ;;=3^795.05
 ;;^UTILITY(U,$J,358.3,20884,1,4,0)
 ;;=4^Cervical High Risk HPV
 ;;^UTILITY(U,$J,358.3,20884,2)
 ;;=^331573
 ;;^UTILITY(U,$J,358.3,20885,0)
 ;;=795.06^^112^1293^33
 ;;^UTILITY(U,$J,358.3,20885,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20885,1,3,0)
 ;;=3^795.06
 ;;^UTILITY(U,$J,358.3,20885,1,4,0)
 ;;=4^Pap w/Cyto Evidence of Malig
 ;;
 ;;$END ROU IBDEI16M
